Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

31.08.2026

1 Biochem Biophys Res Commun
1 BMC Cancer
1 BMC Gastroenterol
8 Dig Dis Sci
2 Endoscopy
2 Gut
1 Hepatology
3 Indian J Gastroenterol
4 J Gastroenterol
1 J Gastroenterol Hepatol
3 J Hepatol
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiol Imaging Cancer
1 Transplantation



    Biochem Biophys Res Commun

  1. WANG S, Li C, Liu Y, Xu L, et al
    Effects of moderate- and high-intensity aerobic exercise on hepatic iron homeostasis, ferroptosis-related changes, and lipid metabolism in high-fat diet-induced MASLD rats.
    Biochem Biophys Res Commun. 2026;834:154467.
    >> Share


    BMC Cancer

  2. YUE X, Kong Y, Huang X, Tang F, et al
    Impact of time to ablation on survival outcomes in patients with colorectal liver metastases: an inverse probability-weighted cohort study.
    BMC Cancer. 2026;26:1011.
    >> Share


    BMC Gastroenterol

  3. MOHAMMADZADEH N, Daeechini AH, Paghe A, Laktarashi HV, et al
    Evaluation of fatty liver disease self-care applications: a systematic review and evaluation of apps using the mobile application rating scale (MARS).
    BMC Gastroenterol. 2026;26:521.
    >> Share


    Dig Dis Sci

  4. HARIHARAN P, Aboona MB, Foote J, Ghani L, et al
    Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease.
    Dig Dis Sci. 2026;71:4340-4349.
    >> Share

  5. MCNALLY BB, Carey EJ
    The Nutrition Landscape in Chronic Liver Disease.
    Dig Dis Sci. 2026;71:4455-4461.
    >> Share

  6. PARK SE, Wollstein Y, Hutchison AL, Paul S, et al
    Recruitment of Minority Patients in Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials.
    Dig Dis Sci. 2026;71:4235-4241.
    >> Share

  7. SHETTY A, Rahal K, Meza J, Saab S, et al
    Gastroenterologist's Guide to Assess for Alcohol Use.
    Dig Dis Sci. 2026;71:4443-4454.
    >> Share

  8. LIOU WL, Pei Y, Teh KK, Cheah MC, et al
    Safety of Statins in an Asian Cohort with Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2026;71:3709-3716.
    >> Share

  9. LIU KS, Liu KE, Sokale IO, Chen Y, et al
    Food Insecurity and Poverty Are Associated with Increased Risk for MASLD Among US Adults.
    Dig Dis Sci. 2026;71:3602-3613.
    >> Share

  10. HUANG D, Zhu Z
    CircRSF1 Promoted HepG2 Cell Proliferation, Migration and Invasion Depending on EIF4A3.
    Dig Dis Sci. 2026;71:3539-3548.
    >> Share

  11. NJEI B, Tanih DN, Al-Ajlouni YA, Boateng S, et al
    AI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis.
    Dig Dis Sci. 2026;71:3476-3488.
    >> Share


    Endoscopy

  12. TAKAHASHI T, Tomishima K, Takasaki Y, Iwabe Y, et al
    Cholangioscopy-guided holmium laser ablation for stent-related mucosal hyperplasia causing recurrent cholangitis after endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026 Aug 27. doi: 10.1055/a-2921-6146.
    >> Share

  13. ASAHINA F, Sagami R, Agario T, Hiroshima Y, et al
    Bile duct stone removal via an endoscopic ultrasound guided-hepaticogastrostomy route created using a B1 puncture technique.
    Endoscopy. 2026 Aug 27. doi: 10.1055/a-2919-0092.
    >> Share


    Gut

  14. JEFFREY AW, Tsochatzis EA, Genesca J, Adams LA, et al
    From pressure to prognosis: establishing a common language for portal hypertension in advanced chronic liver disease.
    Gut. 2026 Aug 25:gutjnl-2026-339845. doi: 10.1136/gutjnl-2026-339845.
    >> Share

  15. ZHU J, Zhang C
    Mortality prediction by rate of skeletal muscle loss in cirrhosis: some methodological considerations.
    Gut. 2026 Aug 24:gutjnl-2026-340267. doi: 10.1136/gutjnl-2026-340267.
    >> Share


    Hepatology

  16. BASTAICH D, Dahman B, Hentschel A, Karki C, et al
    Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.
    Hepatology. 2026 Aug 28. doi: 10.1097/HEP.0000000000001854.
    >> Share


    Indian J Gastroenterol

  17. ANIRVAN P
    ALBI, EZ-ALBI and sarcopenia in hepatocellular carcinoma: Prognostic refinement or repackaging of established risk?
    Indian J Gastroenterol. 2026 Aug 26. doi: 10.1007/s12664-026-02068.
    >> Share

  18. JIANG W
    Reconsidering splenic stiffness measurement for non-invasive esophageal variceal screening in cirrhosis.
    Indian J Gastroenterol. 2026 Aug 24. doi: 10.1007/s12664-026-02055.
    >> Share

  19. VERMA A, Giri S, Sahu SK, Priyadarshini S, et al
    Author's Reply: Reconsidering splenic stiffness measurement for non-invasive esophageal variceal screening in cirrhosis.
    Indian J Gastroenterol. 2026 Aug 28. doi: 10.1007/s12664-026-02062.
    >> Share


    J Gastroenterol

  20. OBA A, Taguchi T, Fujikawa N, Okami S, et al
    Clinical significance of gadoxetate sodium-enhanced MRI for detecting liver metastasis in patients with pancreatic cancer: decadal real-world data analysis in Japan.
    J Gastroenterol. 2026 May 4. doi: 10.1007/s00535-026-02431.
    >> Share

  21. NAKAJIMA A, Okanoue T, Hiasa Y, Takahashi H, et al
    Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.
    J Gastroenterol. 2026 Aug 28. doi: 10.1007/s00535-026-02507.
    >> Share

  22. HASHIMOTO D, Ikeura T, Maekawa A, Nakajima T, et al
    Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study.
    J Gastroenterol. 2026 May 4. doi: 10.1007/s00535-026-02432.
    >> Share

  23. SOUSA JM, Rodriguez-Tajes S, Hernandez-Guerra M, Casado M, et al
    Prevalence and incidence of chronic kidney disease in patients with primary biliary cholangitis.
    J Gastroenterol. 2026 Jun 22. doi: 10.1007/s00535-026-02442.
    >> Share


    J Gastroenterol Hepatol

  24. YI H, Lee HW, Shin JI, Lee HW, et al
    Comparable Predictive Performance of Non-VCTE-Based Machine Learning Model for HBV-Infected Hepatocellular Carcinoma Risk.
    J Gastroenterol Hepatol. 2026 Aug 27. doi: 10.1111/jgh.70686.
    >> Share


    J Hepatol

  25. CHEW V
    Hepatic steatosis as an architect of CRC metastatic niche.
    J Hepatol. 2026 Aug 25:S0168-8278(26)02842-4. doi: 10.1016/j.jhep.2026.
    >> Share

  26. HEDELUND RONN J, Jepsen P, Mellinger J, Innes H, et al
    Alcohol, Cardiometabolic Risk Factors, and Cirrhosis: Ten-Year Risk Estimates from a Population-based Danish Cohort.
    J Hepatol. 2026 Aug 24:S0168-8278(26)02860-6. doi: 10.1016/j.jhep.2026.
    >> Share

  27. SELICEAN SE, Vaisanen E, Wehmeyer M, Hubener P, et al
    Histology alone may underestimate liver cirrhosis despite adequate biopsy quality: evidence from minilaparoscopic liver biopsies.
    J Hepatol. 2026 Aug 27:S0168-8278(26)02857-6. doi: 10.1016/j.jhep.2026.
    >> Share


    PLoS One

  28. CEBALLOS L, Canton C, Gayo V, Moreno L, et al
    Pharmacokinetic barriers to oxfendazole flukicidal efficacy.
    PLoS One. 2026;21:e0355551.
    >> Share

  29. WU R, Xing H, Townsend JP
    Driver mutation impact in Chinese hepatocellular carcinoma.
    PLoS One. 2026;21:e0355717.
    >> Share


    Proc Natl Acad Sci U S A

  30. NEMATI H, Suijkerbuijk SJE, de Graaf J
    Cell competition driven by secreted ligands: Modeling liver metastasis of colorectal cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2531078123.
    >> Share


    Radiol Imaging Cancer

  31. KJAERGAARD U, Bogh N, Aastrup M, Kristensen MH, et al
    Proof-of-Concept Study of Hyperpolarized [1-(13)C]Pyruvate MRI in Participants with Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250784.
    >> Share


    Transplantation

  32. ROBITSCHEK E, Bastani A, Lev S, Horwath K, et al
    Higher Medical Urgency Is Associated With Greater Psychosocial Risk Tolerance in Liver Transplant Listing and Selection.
    Transplantation. 2026 Jun 17. doi: 10.1097/TP.0000000000005800.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016